Randomized Trial of Adjunctive Interleukin-2 in Adults with Pulmonary Tuberculosis

DOI Web Site 被引用文献1件
  • John L. Johnson
    Division of Infectious Diseases, Department of Medicine, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio; University of Arkansas for Medical Sciences, Little Rock, Arkansas; Division of Infectious Diseases, Department of Medicine, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; Department of Medicine, Mulago Hospital and Makerere University; and National TB and Leprosy Control Programme, Kampala, Uganda
  • Emmanuel Ssekasanvu
    Division of Infectious Diseases, Department of Medicine, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio; University of Arkansas for Medical Sciences, Little Rock, Arkansas; Division of Infectious Diseases, Department of Medicine, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; Department of Medicine, Mulago Hospital and Makerere University; and National TB and Leprosy Control Programme, Kampala, Uganda
  • Alphonse Okwera
    Division of Infectious Diseases, Department of Medicine, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio; University of Arkansas for Medical Sciences, Little Rock, Arkansas; Division of Infectious Diseases, Department of Medicine, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; Department of Medicine, Mulago Hospital and Makerere University; and National TB and Leprosy Control Programme, Kampala, Uganda
  • Harriet Mayanja
    Division of Infectious Diseases, Department of Medicine, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio; University of Arkansas for Medical Sciences, Little Rock, Arkansas; Division of Infectious Diseases, Department of Medicine, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; Department of Medicine, Mulago Hospital and Makerere University; and National TB and Leprosy Control Programme, Kampala, Uganda
  • Christina S. Hirsch
    Division of Infectious Diseases, Department of Medicine, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio; University of Arkansas for Medical Sciences, Little Rock, Arkansas; Division of Infectious Diseases, Department of Medicine, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; Department of Medicine, Mulago Hospital and Makerere University; and National TB and Leprosy Control Programme, Kampala, Uganda
  • Joseph G. Nakibali
    Division of Infectious Diseases, Department of Medicine, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio; University of Arkansas for Medical Sciences, Little Rock, Arkansas; Division of Infectious Diseases, Department of Medicine, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; Department of Medicine, Mulago Hospital and Makerere University; and National TB and Leprosy Control Programme, Kampala, Uganda
  • Dana Drzayich Jankus
    Division of Infectious Diseases, Department of Medicine, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio; University of Arkansas for Medical Sciences, Little Rock, Arkansas; Division of Infectious Diseases, Department of Medicine, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; Department of Medicine, Mulago Hospital and Makerere University; and National TB and Leprosy Control Programme, Kampala, Uganda
  • Kathleen D. Eisenach
    Division of Infectious Diseases, Department of Medicine, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio; University of Arkansas for Medical Sciences, Little Rock, Arkansas; Division of Infectious Diseases, Department of Medicine, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; Department of Medicine, Mulago Hospital and Makerere University; and National TB and Leprosy Control Programme, Kampala, Uganda
  • W. Henry Boom
    Division of Infectious Diseases, Department of Medicine, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio; University of Arkansas for Medical Sciences, Little Rock, Arkansas; Division of Infectious Diseases, Department of Medicine, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; Department of Medicine, Mulago Hospital and Makerere University; and National TB and Leprosy Control Programme, Kampala, Uganda
  • Jerrold J. Ellner
    Division of Infectious Diseases, Department of Medicine, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio; University of Arkansas for Medical Sciences, Little Rock, Arkansas; Division of Infectious Diseases, Department of Medicine, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; Department of Medicine, Mulago Hospital and Makerere University; and National TB and Leprosy Control Programme, Kampala, Uganda
  • Roy D. Mugerwa
    Division of Infectious Diseases, Department of Medicine, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio; University of Arkansas for Medical Sciences, Little Rock, Arkansas; Division of Infectious Diseases, Department of Medicine, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; Department of Medicine, Mulago Hospital and Makerere University; and National TB and Leprosy Control Programme, Kampala, Uganda

収録刊行物

被引用文献 (1)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ